Harvard Bioscience (HBIO) Assets (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Assets of $77.9 million for Q1 2026, down 2.33% year-over-year from $79.8 million in Q1 2025, and down 2.66% quarter-over-quarter from $80.1 million in Q4 2025.
Harvard Bioscience (HBIO) Assets (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Assets for 17 consecutive years, with $77.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 2.33% year-over-year to $77.9 million; the TTM figure through Mar 2026 stood at $77.9 million (down 2.33% YoY), while the FY2025 annual figure was $80.1 million, down 36.77% from the prior year.
- Assets declined to $77.9 million in Q1 2026 per HBIO's latest filing, from $80.1 million in the prior quarter.
- Across five years, Assets topped out at $158.0 million in Q1 2022 and bottomed at $77.9 million in Q1 2026.
- Historically, Assets has averaged $122.8 million across 5 years, with a median of $133.2 million in 2024.
- Annual changes were most pronounced in 2022 — Assets increased 4.49% — and 2025, when it tumbled 40.57%.
- Harvard Bioscience's Assets stood at $145.4 million in 2022, then slipped by 5.5% to $137.4 million in 2023, then decreased by 7.81% to $126.6 million in 2024, then slumped by 36.77% to $80.1 million in 2025, then slipped by 2.66% to $77.9 million in 2026.
- Business Quant data shows HBIO's Assets at $77.9 million in Q1 2026, $80.1 million in Q4 2025, and $78.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | 76.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 76.29 Mn |
| Mar 31, 2026 | 77.94 Mn |
| Dec 31, 2025 | 80.07 Mn |
| Sep 30, 2025 | 77.99 Mn |
| Jun 30, 2025 | 80.09 Mn |
| Mar 31, 2025 | 79.80 Mn |
| Dec 31, 2024 | 126.64 Mn |
| Sep 30, 2024 | 131.24 Mn |
| Jun 30, 2024 | 128.91 Mn |
| Mar 31, 2024 | 133.16 Mn |
| Dec 31, 2023 | 137.37 Mn |
| Sep 30, 2023 | 139.74 Mn |
| Jun 30, 2023 | 142.90 Mn |
| Mar 31, 2023 | 145.58 Mn |
| Dec 31, 2022 | 145.36 Mn |
| Sep 30, 2022 | 147.01 Mn |
| Jun 30, 2022 | 155.27 Mn |
| Mar 31, 2022 | 158.04 Mn |
| Dec 31, 2021 | 162.34 Mn |
| Sep 30, 2021 | 153.87 Mn |